BDAIX | RGACX | BDAIX / RGACX | |
Total Expense Ratio | 0.70 | 0.94 | 74% |
Annual Report Gross Expense Ratio | 0.77 | 0.94 | 82% |
Fund Existence | 8 years | 23 years | - |
Gain YTD | 12.977 | 17.183 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 522M | 337B | 0% |
Annual Yield % from dividends | 0.20 | 0.07 | 287% |
Returns for 1 year | 16.02 | 12.22 | 131% |
Returns for 3 years | 117.13 | 71.26 | 164% |
Returns for 5 years | 127.26 | 45.63 | 279% |
Returns for 10 years | N/A | 111.15 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 47.02 | 1.20 | +2.62% |
SPDR® S&P Pharmaceuticals ETF | |||
IQLT | 43.65 | 0.30 | +0.69% |
iShares MSCI Intl Quality Factor ETF | |||
GIGB | 46.56 | 0.03 | +0.06% |
Goldman Sachs Acss Invmt Grd Corp Bd ETF | |||
DVSPF | 4.90 | N/A | N/A |
Dividend 15 Split Corp. | |||
MMCA | 21.70 | -0.02 | -0.09% |
NYLI MacKay California Muni Intmdt ETF |